Revisiting Recommendations on Drug Resistance from Past Studies

Revisiting Recommendations Jessica Pickett Drug Resistance Working Group March 7, 2008

Mapping Out Emerging Solution Areas ,[object Object],[object Object],[object Object],Group Discussion: What’s worked, what hasn’t, and where we can make a difference.

Preliminary Sources ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Key Considerations ,[object Object],[object Object],[object Object],[object Object]

Regulation ,[object Object],[object Object],[object Object],[object Object],[object Object]

Regulation ,[object Object],[object Object],[object Object],[object Object]

Regulation ,[object Object],[object Object],[object Object]

Treatment Protocols & Guidelines ,[object Object],[object Object],[object Object],[object Object],[object Object]

Clinical Environment ,[object Object],[object Object],[object Object],[object Object],[object Object]

Clinical Environment ,[object Object],[object Object],[object Object],[object Object]

Surveillance & Diagnostic Capacity ,[object Object],[object Object],[object Object],[object Object]

Surveillance & Diagnostic Capacity ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Surveillance ,[object Object],[object Object],[object Object]

Information Disclosure & Best Practices ,[object Object],[object Object],[object Object],[object Object]

[object Object],[object Object],[object Object],[object Object],[object Object],Information Disclosure & Best Practices

Health Systems Which recommendations have been successful? Which ones haven’t? Why not?

Prescriber Behavior ,[object Object],[object Object],[object Object],[object Object]

Prescriber Behavior ,[object Object],[object Object],[object Object],[object Object],[object Object]

Prescriber Behavior ,[object Object],[object Object]

Patient Behavior ,[object Object],[object Object],[object Object],[object Object]

Patient Behavior ,[object Object],[object Object]

Behavior Which recommendations have been successful? Which ones haven’t? Why not?

Diagnostics Development ,[object Object],[object Object],[object Object],[object Object]

Diagnostics Development ,[object Object],[object Object],[object Object],[object Object],[object Object]

Drug Financing ,[object Object],[object Object],[object Object],[object Object],[object Object]

Drug Financing ,[object Object],[object Object],[object Object],[object Object]

Drug Financing ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Patents & Regulatory Processes ,[object Object],[object Object],[object Object],[object Object],[object Object]

Patents & Regulatory Processes ,[object Object],[object Object],[object Object],[object Object]

Technology Which recommendations have been successful? Which ones haven’t? Why not?

Opportunities for Impact Where should the Working Group focus? And what can we do differently?

ANNEX A Recommendations: External Factors

Advocacy ,[object Object],[object Object],[object Object],[object Object]

Agricultural Use of Antimicrobials ,[object Object],[object Object],[object Object],[object Object],[object Object]

Agricultural Use of Antimicrobials ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Revisiting Recommendations on Drug Resistance from Past Studies

Revisiting Recommendations on Drug Resistance from Past Studies

Recommandé

Recommandé

Contenu connexe

Tendances

Tendances (20)

Similaire à Revisiting Recommendations on Drug Resistance from Past Studies

Similaire à Revisiting Recommendations on Drug Resistance from Past Studies (20)

Dernier

Dernier (20)

Revisiting Recommendations on Drug Resistance from Past Studies